+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Anti-Obesity Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Obesity Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 121 Pages
  • Global
From
GLP-1 Analogues Market - Global Strategic Business Report - Product Thumbnail Image

GLP-1 Analogues Market - Global Strategic Business Report

  • Report
  • October 2026
  • 474 Pages
  • Global
From
From
Diabetes Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Diabetes Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 191 Pages
  • Global
From
From
Type 1 Diabetes Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Type 1 Diabetes Drug Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator